SeaSpine Holdings Corporation (NASDAQ:SPNE) Files An 8-K Results of Operations and Financial Condition

SeaSpine Holdings Corporation (NASDAQ:SPNE) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02

Results of Operations and Financial Condition.
On May 4, 2017, SeaSpine Holdings Corporation issued a press
release announcing its financial results for the three months
ended March 31, 2017. A copy of the press release is furnished as
Exhibit 99.1 hereto.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits.
The list of exhibits called for by this Item is incorporated by
reference to the Exhibit Index immediately following the page of
this report.
The information set forth under Item 2.02 and in Exhibit 99.1 is
not being filed for purposes of Section 18 of the Securities
Exchange Act of 1934 and is not to be incorporated by reference
into any filing of the registrant, under the Securities Act of
1933 or the Securities Exchange Act of 1934, whether made before
or after the date hereof, regardless of any general incorporation
language in any such filing, except as shall be expressly set
forth by specific reference in such a filing.


About SeaSpine Holdings Corporation (NASDAQ:SPNE)

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip and extremities procedures.

SeaSpine Holdings Corporation (NASDAQ:SPNE) Recent Trading Information

SeaSpine Holdings Corporation (NASDAQ:SPNE) closed its last trading session down -0.17 at 7.54 with 10,568 shares trading hands.

An ad to help with our costs